LAPOINTE ANTHONY GREGG
CIK: 0001331860
Director
Primary company: SOLIGENIX, INC. (SNGX)
LAPOINTE ANTHONY GREGG is a corporate insider at SOLIGENIX, INC. (SNGX) filing SEC Form 4 transactions. 84 transactions across 7 companies, totaling $200,000 in purchases and $0 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
RIGEL PHARMACEUTICALS INC RIGL | Award | 5,750 | - | - | 18,250 | 5/15/2026 Filed: 5/15/2026 | Filing → |
SOLIGENIX, INC. SNGX | Award | 17,647 | - | - | 17,647 | 6/20/2025 Filed: 6/20/2025 | Filing → |
Astria Therapeutics, Inc. ATXS | Award | 26,550 | - | - | 26,550 | 6/11/2025 Filed: 6/12/2025 | Filing → |
RIGEL PHARMACEUTICALS INC RIGL | Award | 3,000 | - | - | 3,000 | 5/23/2025 Filed: 5/28/2025 | Filing → |
RIGEL PHARMACEUTICALS INC RIGL | Award | 2,500 | - | - | 12,500 | 5/23/2025 Filed: 5/28/2025 | Filing → |
SOLIGENIX, INC. SNGX | Award | 8,646 | - | - | 8,646 | 12/12/2024 Filed: 12/13/2024 | Filing → |
Astria Therapeutics, Inc. ATXS | Award | 14,100 | - | - | 14,100 | 6/5/2024 Filed: 6/6/2024 | Filing → |
RIGEL PHARMACEUTICALS INC RIGL | Award | 30,000 | - | - | 30,000 | 5/25/2024 Filed: 5/29/2024 | Filing → |
RIGEL PHARMACEUTICALS INC RIGL | Award | 25,000 | - | - | 100,000 | 5/25/2024 Filed: 5/29/2024 | Filing → |
SOLIGENIX, INC. SNGX | Award | 38,136 | $0.00 | $0 | 38,136 | 12/15/2023 Filed: 12/15/2023 | Filing → |
RIGEL PHARMACEUTICALS INC RIGL | Award | 30,000 | $0.00 | $0 | 30,000 | 5/26/2023 Filed: 7/12/2023 | Filing → |
RIGEL PHARMACEUTICALS INC RIGL | Award | 25,000 | $0.00 | $0 | 75,000 | 5/26/2023 Filed: 7/12/2023 | Filing → |
Astria Therapeutics, Inc. ATXS | Award | 14,100 | $0.00 | $0 | 14,100 | 6/2/2023 Filed: 6/6/2023 | Filing → |
SOLIGENIX, INC. SNGX | Award | 46,154 | $0.00 | $0 | 129,747 | 11/17/2022 Filed: 11/21/2022 | Filing → |
Astria Therapeutics, Inc. ATXS | Award | 8,333 | $0.00 | $0 | 8,333 | 6/9/2022 Filed: 6/21/2022 | Filing → |
Astria Therapeutics, Inc. ATXS | Award | 8,333 | $0.00 | $0 | 8,333 | 6/9/2022 Filed: 6/9/2022 | Filing → |
RIGEL PHARMACEUTICALS INC RIGL | Award | 30,000 | $0.00 | $0 | 30,000 | 5/20/2022 Filed: 5/23/2022 | Filing → |
RIGEL PHARMACEUTICALS INC RIGL | Award | 25,000 | $0.00 | $0 | 50,000 | 5/20/2022 Filed: 5/23/2022 | Filing → |
SOLIGENIX, INC. SNGX | Award | 29,126 | $0.00 | $0 | 29,126 | 9/23/2021 Filed: 9/24/2021 | Filing → |
CATABASIS PHARMACEUTICALS INC CATB | Award | 100,000 | $0.00 | $0 | 100,000 | 6/2/2021 Filed: 6/2/2021 | Filing → |
RIGEL PHARMACEUTICALS INC
RIGL
Type
Award
Shares
5,750
Price
-
Value
-
SOLIGENIX, INC.
SNGX
Type
Award
Shares
17,647
Price
-
Value
-
Astria Therapeutics, Inc.
ATXS
Type
Award
Shares
26,550
Price
-
Value
-
RIGEL PHARMACEUTICALS INC
RIGL
Type
Award
Shares
3,000
Price
-
Value
-
RIGEL PHARMACEUTICALS INC
RIGL
Type
Award
Shares
2,500
Price
-
Value
-
SOLIGENIX, INC.
SNGX
Type
Award
Shares
8,646
Price
-
Value
-
Astria Therapeutics, Inc.
ATXS
Type
Award
Shares
14,100
Price
-
Value
-
RIGEL PHARMACEUTICALS INC
RIGL
Type
Award
Shares
30,000
Price
-
Value
-
RIGEL PHARMACEUTICALS INC
RIGL
Type
Award
Shares
25,000
Price
-
Value
-
SOLIGENIX, INC.
SNGX
Type
Award
Shares
38,136
Price
$0.00
Value
$0
RIGEL PHARMACEUTICALS INC
RIGL
Type
Award
Shares
30,000
Price
$0.00
Value
$0
RIGEL PHARMACEUTICALS INC
RIGL
Type
Award
Shares
25,000
Price
$0.00
Value
$0
Astria Therapeutics, Inc.
ATXS
Type
Award
Shares
14,100
Price
$0.00
Value
$0
SOLIGENIX, INC.
SNGX
Type
Award
Shares
46,154
Price
$0.00
Value
$0
Astria Therapeutics, Inc.
ATXS
Type
Award
Shares
8,333
Price
$0.00
Value
$0
Astria Therapeutics, Inc.
ATXS
Type
Award
Shares
8,333
Price
$0.00
Value
$0
RIGEL PHARMACEUTICALS INC
RIGL
Type
Award
Shares
30,000
Price
$0.00
Value
$0
RIGEL PHARMACEUTICALS INC
RIGL
Type
Award
Shares
25,000
Price
$0.00
Value
$0
SOLIGENIX, INC.
SNGX
Type
Award
Shares
29,126
Price
$0.00
Value
$0
CATABASIS PHARMACEUTICALS INC
CATB
Type
Award
Shares
100,000
Price
$0.00
Value
$0
AI Agent
Try asking...